So-Young International (NASDAQ:SY – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, November 20th. So-Young International has set its Q3 2024 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.
So-Young International (NASDAQ:SY – Get Free Report) last issued its quarterly earnings results on Friday, August 23rd. The company reported $0.02 earnings per share (EPS) for the quarter. The firm had revenue of $56.06 million for the quarter. So-Young International had a return on equity of 1.32% and a net margin of 2.23%.
So-Young International Price Performance
SY opened at $0.89 on Monday. The stock has a market capitalization of $91.69 million, a price-to-earnings ratio of 22.21 and a beta of 0.91. So-Young International has a 12 month low of $0.66 and a 12 month high of $1.52. The business has a 50-day moving average of $0.92 and a two-hundred day moving average of $0.99.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on So-Young International
About So-Young International
So-Young International Inc operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com.
Featured Stories
- Five stocks we like better than So-Young International
- What is the Euro STOXX 50 Index?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Top Stocks Investing in 5G Technology
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Are Trending Stocks? Trending Stocks Explained
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for So-Young International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for So-Young International and related companies with MarketBeat.com's FREE daily email newsletter.